https://www.taxtmi.com/news?id=70780 An exclusive licensing and supply agreement assigns Kashiv responsibility for regulatory registration, manufacturing and supply of a complex peptide product, while Intas will commercialize in India and Accord will commercialize and distribute in Europe and the UK, allocating territorial rights and distinct regulatory, supply and commercial roles between the parties. en-us Tue, 10 Feb 2026 16:31:04 +0530 Tue, 10 Feb 2026 16:31:04 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=70780 An exclusive licensing and supply agreement assigns Kashiv responsibility for regulatory registration, manufacturing and supply of a complex peptide product, while Intas will commercialize in India and Accord will commercialize and distribute in Europe and the UK, allocating territorial rights and distinct regulatory, supply and commercial roles between the parties. News - Tue, 10 Feb 2026 16:31:04 +0530 https://www.taxtmi.com/news?id=70780